'Microbiological finding' sees a halt to GSK/Anacor's antibiotic trials
07 February 2012
Pial Ganguli
Please Login to read the full article.
07 February 2012
Pial Ganguli
Please Login to read the full article.
RELATED CONTENT
NEWS
- MMV ups funding under deal with Anacor to allow Phase I trial of malaria candidate
- Anacor, GSK revise R&D pact on boron-containing anti-infective drug candidates
- GSK snags $38.5 million BARDA contract to pursue Gram-negative antibiotic
- FDA: J&J Doribax pneumonia study halted on higher deaths
ANALYSIS
Other Informa Analysis
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
